Wumatech (ISPR.US/ISPIRE) releases financial performance for FY 2023.
According to the performance report, ISPIRE's revenue for the fiscal year 2023 increased by 31.2%, reaching $115.6 million. Out of this total:
The revenue from CBD vaporization products has seen a remarkable growth of 100.4%, reaching $40 million. On the other hand, the revenue from e-cigarette products has grown by 10.9%, amounting to $75.6 million.
ISPIRE projects potential growth for its CBD vaporization business to be between 100% and 125% in the fiscal year 2024. Meanwhile, the potential growth for its e-cigarette products is estimated to be between 25% and 40%.
Note: ISPIRE's fiscal year ends on June 30, 2023.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
